A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

NCT04316585 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: GSK2982772
DRUG: Placebo

Sponsor

GlaxoSmithKline